Results for “”

Entry Author Date Location
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants 04/18/19 Boston
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More 04/12/19 National
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices 04/09/19 National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More 03/22/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Drug-Price Watchdog ICER Dives into Trump-Fueled Pharma Rebate Debate 03/13/19 National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Retailers Turn to Analytics, 3D Tech to Promote Fit, Reduce Returns 03/04/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away 02/26/19 National
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
“Stigma is Going Away”: Cannabis IP is Thorny, But Not Impossible 02/15/19 Detroit Ann Arbor
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More 02/15/19 National
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans 02/12/19 National
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
Carbonite Buys Webroot for $618M to Offer Security with a Safety Net 02/07/19 Boston
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Equidate, Re-Named Forge Global, Boosts Series B to $85M 01/29/19 San Francisco
Norwest VC Eyes Waves of Change in A.I., Marketing, Cloud for 2019 01/28/19 San Francisco
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More 01/25/19 National
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter 01/16/19 National
Page 1 of 37 next page »